Literature DB >> 220964

The effects of lipid phase transitions on the interaction of mitochondrial NADH--ubiquinone oxidoreductase with ubiquinol--cytochrome c oxidoreductase.

C Heron, M G Gore, C I Ragan.   

Abstract

1. The endogenous phosphatidylcholine and phosphatidylethanolamine of Complexes I and III from bovine heart mitochondria may be completely replaced with 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine with at least partial retention of activity. 2. The lipid-replaced enzymes associate in 1:1 molar ratio to give a Complex I--III unit catalysing NADH-cytochrome c oxidoreductase activity. 3. On increasing the concentration of ubiquinone-10 and the synthetic phospholipid, the lipid-replaced Complexes appear to operate independently of each other as in the natural membrane. Thus the lipid-replaced enzymes associate in exactly the same ways as the enzymes containing natural phospholipids. 4. Arrhenius plots of NADH--cytochrome c oxidoreductase activity reconstituted from lipid-replaced Complexes I and III exhibit changes in slope at 24 degrees C. When the concentrations of phospholipid and ubiquinone-10 are increased, the Arrhenius plots show discontinuities at 24 degrees C as well as changes in slope. 5. The kinetics of cytochrome b reduction by NADH were measured in mixtures containing 2 mol of Complex III/mol of Complex I. When the enzymes contained natural phospholipids. the reduction kinetics were biphasic. When the enzymes had been supplemented with further phospholipid and ubiquinone-10 the kinetics were monophasic. When lipid-replaced enzymes were supplemented with 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine and ubiquinone-10, reduction of cytochrome b was monophasic above the phase-transition temperature of the lipid but biphasic below it. 6. These findings are interpreted in terms of the model for the interaction of Complexes in the natural membrane proposed by Heron, Ragan & Trum-power [(1978) Biochem. J. 174, 791--800].

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220964      PMCID: PMC1186530          DOI: 10.1042/bj1780415

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Studies on the electron transfer system. L. On the mechanism of reconstitution of the mitochondrial electron transfer system.

Authors:  L R FOWLER; S H RICHARDSON
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

2.  Studies on the electron transfer system. XL. Preparation and properties of mitochondrial DPNH-coenzyme Q reductase.

Authors:  Y HATEFI; A G HAAVIK; D E GRIFFITHS
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  Studies on the electron transfer system. XLII. Reconstitution of the electron transfer system.

Authors:  Y HATEFI; A G HAAVIK; L R FOWLER; D E GRIFFITHS
Journal:  J Biol Chem       Date:  1962-08       Impact factor: 5.157

4.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

5.  The interaction between mitochondrial NADH-ubiquinone oxidoreductase and ubiquinol-cytochrome c oxidoreductase. Evidence for stoicheiometric association.

Authors:  C I Ragan; C Heron
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

6.  The interaction between mitochondrial NADH-ubiquinone oxidoreductase and ubiquinol-cytochrome c oxidoreductase. Restoration of ubiquinone-pool behaviour.

Authors:  C Heron; C I Ragan; B L Trumpower
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Possible molecular mechanisms of the protonmotive function of cytochrome systems.

Authors:  P Mitchell
Journal:  J Theor Biol       Date:  1976-10-21       Impact factor: 2.691

9.  NADH-ubiquinone oxidoreductase.

Authors:  C I Ragan
Journal:  Biochim Biophys Acta       Date:  1976-11-30

10.  The role of phospholipids in the reduction of ubiquinone analogues by the mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase complex.

Authors:  C I Ragan
Journal:  Biochem J       Date:  1978-06-15       Impact factor: 3.857

View more
  7 in total

1.  The effect of rate limitation by cytochrome c on the redox state of the ubiquinone pool in reconstituted NADH: cytochrome c reductase.

Authors:  J S Reed; C I Ragan
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

2.  Regulation of electron transfer by the quinone pool.

Authors:  C I Ragan; J S Reed
Journal:  J Bioenerg Biomembr       Date:  1986-10       Impact factor: 2.945

Review 3.  Role of mobility of redox components in the inner mitochondrial membrane.

Authors:  G Lenaz
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

4.  The reconstitution of L-3-glycerophosphate-cytochrome c oxidoreductase from L-3-glycerophosphate dehydrogenase, ubiquinone-10 and ubiquinol-cytochrome c oxidoreductase.

Authors:  I R Cottingham; C I Ragan
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

5.  Cytochrome c mediates electron transfer between ubiquinol-cytochrome c reductase and cytochrome c oxidase by free diffusion along the surface of the membrane.

Authors:  R J Froud; C I Ragan
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

6.  Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein.

Authors:  Christopher E Ellis; Eric J Murphy; Drake C Mitchell; Mikhail Y Golovko; Fernando Scaglia; Gwendolyn C Barceló-Coblijn; Robert L Nussbaum
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Identification of the subunits of bovine heart mitochondrial NADH dehydrogenase that are exposed to the phospholipid bilayer by photo-labelling with 5-iodonaphth-1-yl azide.

Authors:  F G Earley; C I Ragan
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.